array:24 [ "pii" => "S2341192922000348" "issn" => "23411929" "doi" => "10.1016/j.redare.2021.02.008" "estado" => "S300" "fechaPublicacion" => "2022-02-01" "aid" => "1289" "copyright" => "Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Revista Española de Anestesiología y Reanimación (English Version). 2022;69:120-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0034935621000967" "issn" => "00349356" "doi" => "10.1016/j.redar.2021.02.002" "estado" => "S300" "fechaPublicacion" => "2022-02-01" "aid" => "1289" "copyright" => "Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Esp Anestesiol Reanim. 2022;69:120-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA AL DIRECTOR</span>" "titulo" => "Impacto de la terapia con corticoides en la supervivencia de los pacientes críticos con COVID-19 ingresados en una unidad de cuidados intensivos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "120" "paginaFinal" => "121" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1116 "Ancho" => 1508 "Tamanyo" => 125854 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Análisis de supervivencia (Kaplan-Meier) referido a la supervivencia a los 28 días en los 2 grupos.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Como línea discontinua se muestran los enfermos tratados con terapia corticoidea. La línea continua muestra la supervivencia de los pacientes no tratados con corticoides.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. González-Castro, E. Cuenca Fito, A. Fernández, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco" "autores" => array:6 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "González-Castro" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Cuenca Fito" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Fernández" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Escudero Acha" ] 4 => array:2 [ "nombre" => "J.C." "apellidos" => "Rodríguez Borregán" ] 5 => array:2 [ "nombre" => "Y." "apellidos" => "Peñasco" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341192922000348" "doi" => "10.1016/j.redare.2021.02.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341192922000348?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0034935621000967?idApp=UINPBA00004N" "url" => "/00349356/0000006900000002/v1_202201260835/S0034935621000967/v1_202201260835/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341192922000361" "issn" => "23411929" "doi" => "10.1016/j.redare.2021.03.008" "estado" => "S300" "fechaPublicacion" => "2022-02-01" "aid" => "1305" "copyright" => "Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Revista Española de Anestesiología y Reanimación (English Version). 2022;69:122" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Director</span>" "titulo" => "Fascial blocks in the COVID-19 era: An alternative to consider" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "122" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Bloqueos fasciales en la era COVID-19: una alternativa a considerar" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.T. Fernández Martín, S. López Álvarez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "M.T." "apellidos" => "Fernández Martín" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "López Álvarez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0034935621001122" "doi" => "10.1016/j.redar.2021.03.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0034935621001122?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341192922000361?idApp=UINPBA00004N" "url" => "/23411929/0000006900000002/v1_202203120614/S2341192922000361/v1_202203120614/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S234119292200035X" "issn" => "23411929" "doi" => "10.1016/j.redare.2021.01.005" "estado" => "S300" "fechaPublicacion" => "2022-02-01" "aid" => "1290" "copyright" => "Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Revista Española de Anestesiología y Reanimación (English Version). 2022;69:119-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Director</span>" "titulo" => "Limitations on the temperature measurement of the awake polytraumatic patient" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "119" "paginaFinal" => "120" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Limitaciones de la medición de temperatura en el paciente politraumático despierto" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Blasco Mariño, I. Soteras Martínez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Blasco Mariño" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Soteras Martínez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0034935621000979" "doi" => "10.1016/j.redar.2021.01.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0034935621000979?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234119292200035X?idApp=UINPBA00004N" "url" => "/23411929/0000006900000002/v1_202203120614/S234119292200035X/v1_202203120614/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Director</span>" "titulo" => "Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "120" "paginaFinal" => "121" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. González-Castro, E. Cuenca Fito, A. Fernández, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco" "autores" => array:6 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "González-Castro" "email" => array:1 [ 0 => "jandro120475@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Cuenca Fito" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Fernández" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Escudero Acha" ] 4 => array:2 [ "nombre" => "J.C." "apellidos" => "Rodríguez Borregán" ] 5 => array:2 [ "nombre" => "Y." "apellidos" => "Peñasco" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Impacto de la terapia con corticoides en la supervivencia de los pacientes críticos con COVID-19 ingresados en una unidad de cuidados intensivos" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1603 "Ancho" => 2167 "Tamanyo" => 222265 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Survival curve (Kaplan–Meier) showing 28-day survival in the study groups.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The dashed line shows patients treated with corticosteroid therapy. The solid line shows survival in patients not treated with corticosteroids.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The potential benefit of corticosteroids in the treatment of sepsis or acute respiratory distress syndrome has been evaluated in numerous clinical trials, but their effect on mortality remains controversial. Villar et al. recently demonstrated the efficacy of dexamethasone in patients with acute respiratory distress syndrome of various causes<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Most early studies in corticosteroids for COVID-19 in the context of the current pandemic have been of low quality. However, data from the RECOVERY trial<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> boosted confidence in the positive effect of corticosteroids on mortality in COVID-19 patients who require mechanical ventilation.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In light of these findings, we conducted a retrospective study of all patients admitted to our ICU for SARS-CoV-2 between 15 March and 5 December 2020 in order to analyse the impact of corticosteroid treatment on short-term survival (28 days). Corticosteroid use was recorded as a binary variable (yes or no) if patients received at least 40 mg of methylprednisolone or its equivalent over a period of at least 5 days for the purpose of treating inflammation associated with viral pneumonia.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We performed a descriptive analysis of the sample, followed by a 28-day Kaplan–Meier survival analysis using the time to death variable. Both survival curves were compared using the log-rank test.</p><p id="par0025" class="elsevierStylePara elsevierViewall">A total of 254 patients were admitted over the study period. Twenty-eight patients with unconfirmed SARS-CoV-2 were excluded from the study, leaving 228 patients for analysis, of whom 122 received corticosteroid treatment and 106 did not.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The patients who received corticosteroid treatment were older (difference of 4 years; 95% CI: 0.47–7.53; <span class="elsevierStyleItalic">p</span> = 0.02) and had a higher body mass index (<span class="elsevierStyleItalic">p</span> = 0.03). No differences were found between groups in terms of baseline PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> (<span class="elsevierStyleItalic">p</span> = 0.34) or in the need for mechanical ventilation during ICU stay.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The use of corticosteroids during ICU stay was associated with a significantly greater probability of survival at 28 days (HR: 1.8; 95% CI: 1.04–3.2).</p><p id="par0040" class="elsevierStylePara elsevierViewall">Finally, the Kaplan–Meier survival curve showed statistically significant greater 28-day survival (log-rank <span class="elsevierStyleItalic">p</span> = 0.0345) in the group of patients who received corticosteroid treatment (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">During this pandemic, many patients have received a wide variety of experimental therapies in all manner of combinations, often with minimal scientific evidence for their efficacy, and in such a haphazard fashion that any evaluation of their effect is difficult. The situation, according to some authors, has led to doctors squandering decades of progress in evidence-based medicine out of a desperate desire to “do something” to tackle a new challenge.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The open-label, randomized RECOVERY trial in over 2000 patients treated with corticosteroids vs. over 4000 patients who received standard treatment is one of the most robust studies in the potential impact of corticosteroids on the evolution of patients with SARS-CoV-2 infection. The results showed, among other things, that dexamethasone (6 mg daily) significantly reduced mortality in patients on mechanical ventilation, but not in patients with no respiratory failure. Despite the questionable methodology used, the results precipitated the announcement that corticosteroids were the standard treatment for COVID-19<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>.</p><p id="par0055" class="elsevierStylePara elsevierViewall">However, a recent meta-analysis (with pooled data from 7 studies) reported that the positive effect on mortality disappeared when data from the RECOVERY trial were excluded, indicating that these data were overweighted in the meta-analysis<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a>. Clearly, due to the heterogeneity of the trials performed to date (compounds, dose, patient severity, time of administration, etc.), the results published must be interpreted with caution.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Therefore, although our data show better survival in patients treated with corticosteroids, more powerful studies are needed to clarify which patients will benefit most from this therapy. The administration of corticosteroids can be harmful, insofar as they appear to delay viral shedding and promote superinfections and hyperglycemia<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0065" class="elsevierStylePara elsevierViewall">This manuscript has not received any funding.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflict of interests</span><p id="par0070" class="elsevierStylePara elsevierViewall">All authors acknowledge that they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflict of interests" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: González-Castro A, Cuenca Fito E, Fernández A, Escudero Acha P, Rodríguez Borregán JC, Peñasco Y. Impacto de la terapia con corticoides en la supervivencia de los pacientes críticos con COVID-19 ingresados en una unidad de cuidados intensivos. Rev Esp Anestesiol Reanim. 2022;69:120–121.</p>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1603 "Ancho" => 2167 "Tamanyo" => 222265 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Survival curve (Kaplan–Meier) showing 28-day survival in the study groups.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The dashed line shows patients treated with corticosteroid therapy. The solid line shows survival in patients not treated with corticosteroids.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Villar" 1 => "C. Ferrando" 2 => "D. Martínez" 3 => "A. Ambrós" 4 => "T. Muñoz" 5 => "J.A. Soler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(19)30417-5" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2020" "volumen" => "8" "paginaInicial" => "267" "paginaFinal" => "276" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32043986" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dexamethasone in hospitalized patients with COVID-19—preliminary report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "The RECOVERY Collaborative Group" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2021436" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "384" "paginaInicial" => "693" "paginaFinal" => "704" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32678530" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A living WHO guideline on drugs for COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Lamontagne" 1 => "T. Agoritsas" 2 => "H. Macdonald" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.m3379" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2020" "volumen" => "370" "paginaInicial" => "m3379" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32887691" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between systemic corticosteroids administration and mortality among critically ill patients with Covid-19: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "The WHO Rapid Evidence Appraisal for COVID-19 therapies (REACT) working group" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2020.17023" "Revista" => array:5 [ "tituloSerie" => "JAMA" "fecha" => "2020" "volumen" => "324" "paginaInicial" => "1330" "paginaFinal" => "1341" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Zhu" 1 => "Z.G. She" 2 => "X. Cheng" 3 => "J.J. Qin" 4 => "X.J. Zhang" 5 => "J. Cai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cmet.2020.04.021" "Revista" => array:6 [ "tituloSerie" => "Cell Metab" "fecha" => "2020" "volumen" => "31" "paginaInicial" => "1068" "paginaFinal" => "1077" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32369736" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23411929/0000006900000002/v1_202203120614/S2341192922000348/v1_202203120614/en/main.assets" "Apartado" => array:4 [ "identificador" => "66474" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letter to the Director" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23411929/0000006900000002/v1_202203120614/S2341192922000348/v1_202203120614/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341192922000348?idApp=UINPBA00004N" ]
Journal Information
Vol. 69. Issue 2.
Pages 120-121 (February 2022)
Share
Download PDF
More article options
Vol. 69. Issue 2.
Pages 120-121 (February 2022)
Letter to the Director
Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit
Impacto de la terapia con corticoides en la supervivencia de los pacientes críticos con COVID-19 ingresados en una unidad de cuidados intensivos
Visits
482
A. González-Castro
, E. Cuenca Fito, A. Fernández, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco
Corresponding author
Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain
This item has received
Article information
These are the options to access the full texts of the publication Revista Española de Anestesiología y Reanimación (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail